載入...

Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model

Patients with unresectable hepatocellular carcinoma (HCC) usually have poor prognosis because current monotherapy including surgery, chemotherapy and radiotherapy (RT) are not effective. Combination therapy may be effective to overcome this clinical problem. Here, we proposed the combination of sora...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncotarget
Main Authors: Chen, John Chun-Hao, Chuang, Hui-Yen, Hsu, Fei-Ting, Chen, Yi-Chen, Chien, Yi-Chun, Hwang, Jeng-Jong
格式: Artigo
語言:Inglês
出版: Impact Journals LLC 2016
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356748/
https://ncbi.nlm.nih.gov/pubmed/27863427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13398
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!